We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Modification of (i) Acquisition Agreement and (ii) Associated Seller’s Acquisition NotesAcquisition Agreement • June 18th, 2020 • Cannabis Global, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledJune 18th, 2020 Company Industry JurisdictionThis Modification of Acquisition Agreement (“Modification Agreement”) is entered into by and between Cannabis Global, Inc., a Nevada corporation formerly known as MCTC Holdings, Inc. (hereafter referred to as “CGI”) and Lelantos Biotech., a Wyoming corporation, including without limitation its shareholders, owners, affiliates, control persons, successors and assigns, including, but not limited to, Mt. Fire, LLC, a Nevada limited liability company (“Mt. Fire”), Ma Helen M. Am Is, Inc., a Wyoming Corporation (“Helen M.”), New Horizons Laboratory Services, Inc., a Wyoming Corporation (“New Horizons”), and East West Pharma Group, Inc., a Wyoming Corporation (“East – West”) (or collectively, “Lelantos”). CGI and Lelantos may be referred to individually as a “Party” or collectively as the “Parties.”
ACQUISITION AGREEMENT DATED AS OF FEBRUARY 4, 2020 BY AND BETWEEN MCTC HOLDINGS, INC. AND LELANTOS BIOTECH, INC.Acquisition Agreement • June 5th, 2020 • Cannabis Global, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJune 5th, 2020 Company Industry JurisdictionTHIS ACQUISITION AGREEMENT (“Agreement”) is entered into as of February 12, 2020 (the “Effective Date”), by and between MCTC Holdings, Inc., a Delaware corporation (“MCTC” or “Buyer”), Lelantos Biotech, Inc., a privately held Wyoming Corporation (“Lelantos” or “Seller”), and the Owners of Lelantos (the “Owners”).